GDHB5-Glutamate dehydrogenase

Added to your cart

GDHB5-Glutamate dehydrogenase

Cart subtotal: £0.00

View cart (0) Checkout


Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

Glutamate Dehydrogenase is an enzyme used in liquid and powder laboratory reagents. Our GLDH is extracted from Bovine Liver using multiple precipitation, fractionation, and filtration steps to produce a product of the highest quality, stability, and batch to batch consistency. Glutamate Dehydrogenase can be used in a number of applications including: + Determination of Urea in conjunction with Urease + As an indicator enzyme in the detection of serum GOT/GPT + In the determination of ammonia

More information



  • Associated Activity
  • LDH: less than 0.01% MDH: less than 0.01%
  • Lead Time
  • 10 weeks
  • Storage
  • Store at +2°C to +8°C. DO NOT FREEZE.
  • Shelf Life
  • 4 years
  • Manufacturer Country
  • UK
  • Source
  • Bovine Liver
  • Activity
  • ≥40 U/mg protein
  • EC Number
  • Systematic Name
  • L-Glutamate:NAD(P)+ oxidoreductase (deaminating)
  • Unit Definition
  • That amount of enzyme causing the transformation of one micromole of 2-Oxoglutarate per minute at 25C and pH 7.3. (under assay conditions not containing ADP)
  • Form
  • A suspension in 50% saturated ammonium sulphate solution, pH 7.6.

Technical Documents

Product Specification (55.25KB)

Analytical Procedures (138.98KB)

Product Information (273.9KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox